(VIANEWS) – Shares of EUROAPI (CAC 40: EAPI.PA) slid by a staggering 20.26% in 10 sessions from €15.3 to €12.20 at 13:55 EST on Thursday, following the last session’s downward trend. CAC 40 is dropping 0.26% to €7,305.67, after two successive sessions in a row of losses.
About EUROAPI
Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; prostaglandins; steroids & hormones; and Opiates and controlled substances. The company was incorporated in 2021 and is headquartered in Paris, France.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUROAPI’s stock is considered to be overbought (>=80).
More news about EUROAPI (EAPI.PA).
